Clinical breast exam contribution to breast cancer diagnosis in BRCA mutation carriers vs. average to intermediate risk women.
Tehillah S MenesDouglas ZippelMiri Sklair-LevyEitan FriedmanRinat Bernstein-MolhoRenata FaermannDana Madorsky FeldmanPublished in: Breast cancer research and treatment (2024)
The contribution of CBE to BC diagnosis is marginal for all women including BRCA mutation carriers. In BRCA mutation carriers, CBE appears redundant during the MRI surveillance round.